Literature DB >> 21571779

The vascular adventitia: its role in the arterial injury response.

George E Havelka1, Melina R Kibbe.   

Abstract

The belief that the adventitia serves only a structural purpose has changed over the last decade. Studies have begun to elucidate the role the adventitia plays in the arterial response to injury. The adventitial fibroblast plays an integral part in the development of neointimal hyperplasia. Adiponectin, an adipokine produced from periadventitial adipose tissue, exhibits numerous vasoprotective properties. Stem cells arise, in part, from the adventitia, and stem cell recruitment into the adventitia from the vasa vasorum has been shown to be important in the development of neointimal hyperplasia. The exact role the vasa vasorum plays in neointimal growth is poorly understood and different studies endorse conflicting viewpoints. Thus, understanding the nuances of adventitial pathophysiology will allow us to better appreciate the mechanisms behind the pathology of neointimal hyperplasia. This review will summarize recent findings on the active role the adventitia plays toward the development of neointimal hyperplasia.
© The Author(s) 2011

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21571779     DOI: 10.1177/1538574411407698

Source DB:  PubMed          Journal:  Vasc Endovascular Surg        ISSN: 1538-5744            Impact factor:   1.089


  15 in total

Review 1.  Defining vascular stem cells.

Authors:  Ching-Shwun Lin; Tom F Lue
Journal:  Stem Cells Dev       Date:  2013-01-18       Impact factor: 3.272

2.  Serotonin drives the activation of pulmonary artery adventitial fibroblasts and TGF-β1/Smad3-mediated fibrotic responses through 5-HT(2A) receptors.

Authors:  Chunyan Chen; Xinyuan Han; Fenling Fan; Ya Liu; Tingzhong Wang; Juanjuan Wang; Peijing Hu; Aiqun Ma; Hongyan Tian
Journal:  Mol Cell Biochem       Date:  2014-09-04       Impact factor: 3.396

3.  Long-term effect of PROLI/NO on cellular proliferation and phenotype after arterial injury.

Authors:  Edward S M Bahnson; Ashley K Vavra; Megan E Flynn; Janet M Vercammen; Qun Jiang; Amanda R Schwartz; Melina R Kibbe
Journal:  Free Radic Biol Med       Date:  2015-11-26       Impact factor: 7.376

Review 4.  The critical role of Akt in cardiovascular function.

Authors:  Prasanna Abeyrathna; Yunchao Su
Journal:  Vascul Pharmacol       Date:  2015-05-27       Impact factor: 5.773

Review 5.  Proinflammation of aging central arteries: a mini-review.

Authors:  Mingyi Wang; Robert E Monticone; Edward G Lakatta
Journal:  Gerontology       Date:  2014-08-28       Impact factor: 5.140

6.  Nitric oxide is less effective at inhibiting neointimal hyperplasia in spontaneously hypertensive rats.

Authors:  Nick D Tsihlis; Ashley K Vavra; Janet Martinez; Vanessa R Lee; Melina R Kibbe
Journal:  Nitric Oxide       Date:  2013-10-19       Impact factor: 4.427

7.  Lack of interleukin-1 signaling results in perturbed early vein graft wall adaptations.

Authors:  Peng Yu; Binh T Nguyen; Ming Tao; Tianyu Jiang; Christine R Mauro; Yuqi Wang; C Keith Ozaki
Journal:  Surgery       Date:  2012-07-31       Impact factor: 3.982

8.  Targeting the adventitial microenvironment in pulmonary hypertension: A potential approach to therapy that considers epigenetic change.

Authors:  Kurt R Stenmark; Maria G Frid; Michael Yeager; Min Li; Suzette Riddle; Timothy McKinsey; Karim C El Kasmi
Journal:  Pulm Circ       Date:  2012 Jan-Mar       Impact factor: 3.017

9.  Adventitial gene transfer of catalase attenuates angiotensin II-induced vascular remodeling.

Authors:  Cun-Fei Liu; Jia Zhang; Kai Shen; Ping-Jin Gao; Hai-Ya Wang; Xin Jin; Chao Meng; Ning-Yuan Fang
Journal:  Mol Med Rep       Date:  2014-12-10       Impact factor: 2.952

10.  Calcium micro-depositions in jugular truncular venous malformations revealed by Synchrotron-based XRF imaging.

Authors:  Lorella Pascolo; Alessandra Gianoncelli; Clara Rizzardi; Veronica Tisato; Murielle Salomé; Carla Calligaro; Fabrizio Salvi; David Paterson; Paolo Zamboni
Journal:  Sci Rep       Date:  2014-10-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.